Impaired cued and spatial learning performance and altered cannabinoid CB₁ receptor functionality in the substantia nigra in a rat model of diabetic neuropathy

Behavioural Brain Research
Orla MoriartyDavid P Finn

Abstract

Diabetes, and associated diabetic neuropathic pain, impact negatively on cognitive function. However, the underlying mechanisms remain poorly understood. This study investigated neuropathic pain-related behaviour and cognitive function in the rat streptozotocin (STZ) model of diabetes, and assessed cannabinoid1 (CB1) receptor functionality in discrete brain regions. Male Lister-Hooded rats received STZ (60 mg/kgs.c.) or vehicle. Sensory responses were assessed in von Frey and Hargreaves tests. Cognitive, motor and sensorimotor functions were assessed using novel object recognition and Morris water maze tasks. CB1 receptor functionality was assessed by [(35)S]GTPγS (guanosine 5'-O-[gamma-thio]triphosphate) autoradiography. STZ treatment was associated with mechanical allodynia and thermal hypoalgesia. Novel object recognition was unaltered in diabetic rats. STZ treatment was associated with impaired performance in the Morris water maze acquisition phase, but there were no differences in memory retrieval in the probe trial. Stimulus-response learning in the water maze cued trial was also disrupted in STZ-treated rats, possibly indicating sensorimotor deficits. CB1 receptor agonist-stimulated [(35)S]GTPγS binding was attenuated in...Continue Reading

References

Feb 1, 1984·The Journal of Physiology·M SchwarzP Wand
Aug 1, 1995·Proceedings of the National Academy of Sciences of the United States of America·L J SimS R Childers
Jul 1, 1994·Journal of Neuroscience Methods·S R ChaplanT L Yaksh
Jun 1, 1996·Brain Research. Cognitive Brain Research·J S Andrews
Apr 1, 1997·Current Opinion in Neurobiology·L L BrownT I Lidsky
Oct 12, 2002·Pharmacology, Biochemistry, and Behavior·L P RutledgeM G Kolta
Aug 4, 2004·Psychopharmacology·P Alexander Arguello, J David Jentsch
Dec 14, 2004·Journal of Clinical and Experimental Neuropsychology·Nesrine AwadClaude Messier
Mar 1, 2005·Diabetes Care·Augustina M A BrandsRoy P C Kessels
Jun 28, 2005·European Journal of Pain : EJP·A Vania ApkarianJon-Kar Zubieta
Oct 11, 2005·Neurobiology of Aging·Christopher M Ryan
Oct 15, 2005·Neurobiology of Aging·Geert Jan Biessels, Willem Hendrik Gispen
Jan 2, 2007·Journal of Pain and Symptom Management·Mónica PovedanoJavier Rejas
Jan 5, 2007·Behavioral Neuroscience·Claudio Da CunhaNewton S Canteras
Jan 20, 2007·The AAPS Journal·Andrea G Hohmann, Richard L Suplita
Apr 5, 2007·Nature Protocols·Charles V Vorhees, Michael T Williams
May 1, 2008·Nature Reviews. Drug Discovery·Vincenzo Di Marzo
Sep 12, 2008·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Yanina RevsinMelly S Oitzl
Nov 19, 2008·Psychopharmacology·Leigh V PanlilioSteven R Goldberg
Jan 1, 2008·Current Drug Abuse Reviews·Nadia Solowij, Robert Battisti
Oct 5, 2010·Behavioural Brain Research·Francele Valente PiazzaMarilda da Cruz Fernandes
Jan 11, 2011·Progress in Neurobiology·Orla MoriartyDavid P Finn

❮ Previous
Next ❯

Citations

Nov 28, 2019·International Journal of Molecular Sciences·Maura ArgenzianoFrancesca Rossi
Jun 26, 2021·Pharmacology & Therapeutics·Sorabh Sharma, Craig E Brown

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cannabis & Cognition

The effect of cannabis on cognitive functioning is being explored for short and long-term effects. Recent studies have shown conflicting results, with some showing no significant effects and others showing neuropsychological impairment. Discover the latest research on cannabis and cognition here.

Basal Ganglia

Basal Ganglia are a group of subcortical nuclei in the brain associated with control of voluntary motor movements, procedural and habit learning, emotion, and cognition. Here is the latest research.